We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stem Cell Therapeutics Advances CD47 Antagonist Program into Ind-Enabling Phase

News   Sep 09, 2013

 
Stem Cell Therapeutics Advances CD47 Antagonist Program into Ind-Enabling Phase
 
 
 

RELATED ARTICLES

Platelet-Rich Plasma Does Not Promote Stem Cell-Mediated Cartilage Repair

News

Platelet-rich plasma reportedly improves pain relief and joint function, but it doesn't work the way we thought it did.

READ MORE

Tdap Vaccination for Pregnant Women Does Not Increase Risk of Autism, Finds Study

News

A Kaiser Permanente study of more than 80,000 children born over a 4-year period showed that the prenatal Tdap vaccination (tetanus, diphtheria, acellular pertussis) was not associated with increased risk of autism spectrum disorder in children.

READ MORE

In Apoptosis, Cell Death Spreads Through Perpetuating Waves

News

In a cell, death is akin to falling dominoes, according to a new Stanford study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE